MEIS2 Is an Oncogenic Partner in AML1-ETO-Positive AML

  • Naidu M. Vegi
  • , Josef Klappacher
  • , Franz Oswald
  • , Medhanie A. Mulaw
  • , Amit Mandoli
  • , Verena N. Thiel
  • , Shiva Bamezai
  • , Kristin Feder
  • , Joost H.A. Martens
  • , Vijay P.S. Rawat
  • , Tamoghna Mandal
  • , Leticia Quintanilla-Martinez
  • , Karsten Spiekermann
  • , Wolfgang Hiddemann
  • , Konstanze Döhner
  • , Hartmut Döhner
  • , Hendrik G. Stunnenberg
  • , Michaela Feuring-Buske
  • , Christian Buske

Onderzoeksoutput: Bijdrage aan tijdschriftArtikelpeer review

40 Citaten (Scopus)

Samenvatting

Homeobox genes are known to be key factors in leukemogenesis. Although the TALE family homeodomain factor Meis1 has been linked to malignancy, a role for MEIS2 is less clear. Here, we demonstrate that MEIS2 is expressed at high levels in patients with AML1-ETO-positive acute myeloid leukemia and that growth of AML1-ETO-positive leukemia depends on MEIS2 expression. In mice, MEIS2 collaborates with AML1-ETO to induce acute myeloid leukemia. MEIS2 binds strongly to the Runt domain of AML1-ETO, indicating a direct interaction between these transcription factors. High expression of MEIS2 impairs repressive DNA binding of AML1-ETO, inducing increased expression of genes such as the druggable proto-oncogene YES1. Collectively, these data describe a pivotal role for MEIS2 in AML1-ETO-induced leukemia.

Originele taal-2Engels
Pagina's (van-tot)498-507
Aantal pagina's10
TijdschriftCell reports
Volume16
Nummer van het tijdschrift2
DOI's
StatusGepubliceerd - 12 jul. 2016
Extern gepubliceerdJa

Vingerafdruk

Duik in de onderzoeksthema's van 'MEIS2 Is an Oncogenic Partner in AML1-ETO-Positive AML'. Samen vormen ze een unieke vingerafdruk.

Citeer dit